Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 598,558 |
|
|||||
| News | - | ||||||
| Day High | 25.54 | Low High |
|||||
| Day Low | 24.46 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Myriad Genetics Inc | MYGN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.68 | 2.76% | 25.29 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 24.79 | 24.46 | 25.54 | 25.29 | 24.61 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,123 | 598,558 | US$ 25.11 | US$ 15,032,500 | - | 13.82 - 25.95 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:20:00 | priorref | 131 | US$ 25.29 | USD |
Myriad Genetics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.27B | 89.87M | - | 753.2M | -263.3M | -2.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Myriad Genetics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYGN Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 25.16 | 25.95 | 23.77 | 25.01 | 1,191,457 | 0.13 | 0.52% |
| 1 Month | 18.47 | 25.95 | 17.90 | 22.02 | 951,970 | 6.82 | 36.92% |
| 3 Months | 23.01 | 25.95 | 17.90 | 21.61 | 766,112 | 2.28 | 9.91% |
| 6 Months | 17.43 | 25.95 | 16.80 | 20.97 | 698,354 | 7.86 | 45.09% |
| 1 Year | 18.66 | 25.95 | 13.82 | 19.97 | 631,306 | 6.63 | 35.53% |
| 3 Years | 27.12 | 36.9547 | 13.82 | 22.55 | 588,544 | -1.83 | -6.75% |
| 5 Years | 26.25 | 48.40 | 9.24 | 22.33 | 734,422 | -0.96 | -3.66% |
Myriad Genetics Description
| Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 35-gene panel with the capability to identify the elevated risk of developing eight types of cancer. Other diagnostic products include BRACAnalysisCDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; Prequel, with is a noninvasive prenatal test; and Prolaris, which identifies prostate cancer patients that can pursue active surveillance. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies. |
